Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis

PURPOSE: Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties. We assessed the benefits and harms of AT III in critically ill patients. METHODS: We searched from inception to 27 August 2015 in CENTRAL, MEDLINE, EMBASE, CAB, BIOSIS and CINAHL. We included randomized control...

Descripción completa

Detalles Bibliográficos
Autores principales: Allingstrup, Mikkel, Wetterslev, Jørn, Ravn, Frederikke B., Møller, Ann Merete, Afshari, Arash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095103/
https://www.ncbi.nlm.nih.gov/pubmed/26862016
http://dx.doi.org/10.1007/s00134-016-4225-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095103/
https://www.ncbi.nlm.nih.gov/pubmed/26862016
http://dx.doi.org/10.1007/s00134-016-4225-7

Ejemplares similares